A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma. (25th September 2015) - Rosenthal, Allison; Kumar, Shaji; Hofmeister, Craig; Laubach, Jacob; Vij, Ravi; Dueck, Amylou; Gano, Katherine; Stewart, A. Keith